Favaretto, Alice
Lazzarotto, Andrea
Margoni, Monica
Poggiali, Davide
Gallo, Paolo http://orcid.org/0000-0003-3886-4181
Article History
Received: 10 August 2017
Accepted: 14 December 2017
First Online: 29 January 2018
Ethics approval and consent to participate
: NA
: NA
: During the past 3 years, Professor P. Gallo has had a financial relationship (lecturer, member of advisory boards and/or consultant or investigator) with Biogen Italy, TEVA, Merck-Serono, Novartis Farma, Sanofi-Genzyme, Roche and Almirall. Dr. A. Favaretto has received funding for travel and speaker honoraria in the last 3 years from Teva, Novartis, Biogen Italy, and Genzyme. A. Lazzarotto, M. Margoni, and D. Poggiali have nothing to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.